News

Harvard Students Return to Changed Campus Covid Restrictions

News

Some Harvard Classes Start Spring Semester Online Due to Omicron Surge

News

Harvard’s Graduate Student Union Files Complaint Over Spring Covid Policies

News

Harvard Kennedy School Misinformation Review Retracts Article, Admitting Editorial 'Failure'

News

Students, Faculty Reflect on 100 Years of Harvard Business School’s Case Method

A New Deal On Lifesaving Drugs

Rethinking how Harvard’s discoveries reach the world's poorest. First up: a new TB vaccine

Harvard scientist David A. Edwards has developed a new spray vaccine for tuberculosis that could save thousands and help transform tech transfer.
Harvard scientist David A. Edwards has developed a new spray vaccine for tuberculosis that could save thousands and help transform tech transfer.
By Nicholas M. Ciarelli and Daniel J. T. Schuker, Crimson Staff Writerss

‘Research for $ale’ is an examination of the process known as "tech transfer," by which innovations move from Harvard’s labs to consumers and patients across the globe. It is funded by the Christopher J. Georges Fellowship, an annual grant awarded to journalists on the staff of The Crimson and administered by the Nieman Foundation for Journalism. The fellowship supports investigative projects that exemplify Chris Georges’ commitment to in-depth reporting on issues of enduring social value and the human impact of public policy.Chris Georges ’87 was an executive editor of The Crimson and a magna cum laude graduate of the College. As a reporter in The Wall Street Journal’s Washington bureau, he covered politics, economics, and budget issues. Three of his stories on the welfare system were nominated for a Pulitzer Prize in 1997. Georges also served as editor of The Washington Monthly and worked at CNN, The New York Times, and The Washington Post. He died in 1998 at age 33 from complications related to lupus.

Want to keep up with breaking news? Subscribe to our email newsletter.

Tags